We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
-0.67%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
–
AUM
$274M
AUM Growth
+$22.1M
Cap. Flow
+$26.5M
Cap. Flow %
9.66%
Top 10 Hldgs %
53.23%
Holding
76
New
9
Increased
45
Reduced
7
Closed
8

Top Buys

Rank Stock Value
1
CGW icon
Invesco S&P Global Water Index ETF
CGW
+$20.3M
2
SHE icon
State Street SPDR MSCI USA Gender Diversity ETF
SHE
+$4.77M
3
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$922K
4
HEEM icon
iShares Currency Hedged MSCI Emerging Markets
HEEM
+$683K
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$408K

Top Sells

Rank Stock Value
1
TAN icon
Invesco Solar ETF
TAN
+$3.87M
2
FNV icon
Franco-Nevada
FNV
+$276K
3
CVS icon
CVS Health
CVS
+$237K
4
NEM icon
Newmont
NEM
+$235K
5
B
Barrick Mining
B
+$207K

Sector Composition

Rank Sector Weight
1 Financials 0.82%
2 Healthcare 0.73%
3 Technology 0.26%
4 Consumer Discretionary 0.26%
5 Industrials 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
51
Gilead Sciences
GILD
$167B
$243K 0.09%
3,440
-825
-19% -$58K
REGN icon
52
Regeneron Pharmaceuticals
REGN
$70.9B
$233K 0.08%
382
-40
-9% -$24.8K
ESGD icon
53
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
$213K 0.08%
2,721
– –
BABA icon
54
Alibaba
BABA
$276B
$200K 0.07%
+1,348
New +$245K
VRNA
55
DELISTED
Verona Pharma
VRNA
$181K 0.07%
33,156
+17,650
+114% +$103K
DYAI icon
56
Dyadic International
DYAI
$45.9M
$178K 0.06%
31,671
+425
+1% +$1.98K
PRVB
57
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$135K 0.05%
+21,102
New +$136K
ORTX
58
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$118K 0.04%
5,107
+3,378
+195% +$100K
GERN icon
59
Geron
GERN
$924M
$113K 0.04%
82,336
+5,850
+8% +$7.81K
AGI icon
60
Alamos Gold
AGI
$11.9B
$102K 0.04%
14,250
-14,250
-50% -$110K
KGC icon
61
Kinross Gold
KGC
$27B
$86K 0.03%
16,000
-16,000
-50% -$95.8K
PSTX
62
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$72K 0.03%
+10,345
New +$88.8K
CTMX icon
63
CytomX Therapeutics
CTMX
$788M
$68K 0.02%
+13,394
New +$71.7K
EIGR
64
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$68K 0.02%
336
+2
+0.6% +$476
ADAM
65
Adamas Trust
ADAM
$807M
$43K 0.02%
2,500
– –
PEI
66
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$19K 0.01%
667
– –
SPY icon
67
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$14K 0.01%
+2,000
New +$882K
NVDA icon
68
CALL
NVIDIA
NVDA
$4.91T
$7K ﹤0.01%
+2,000
New +$41.5K
AEM icon
69
Agnico Eagle Mines
AEM
$68.5B
– –
-3,350
Closed -$203K
CVS icon
70
CVS Health
CVS
$137B
– –
-2,827
Closed -$237K
FNV icon
71
Franco-Nevada
FNV
$38.7B
– –
-1,900
Closed -$276K
B
72
Barrick Mining
B
$58.5B
– –
-10,000
Closed -$207K
HSIC icon
73
Henry Schein
HSIC
$10B
– –
-2,808
Closed -$206K
NEM icon
74
Newmont
NEM
$95.8B
– –
-3,700
Closed -$235K
SPY icon
75
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$774B
– –
-5,000
Closed -$51K
1 2
3
4

Similar funds

NC
nVerses Capital Wellington, Florida $110M AUM
PXPO
Peak XV Partners Operations Trianon, Mauritius $110M AUM 43.09% 1-Year Est. Return
OWA
OakTrust Wealth Advisors Wilton, Connecticut $110M AUM
MCM
Masterton Capital Management New York $110M AUM 3.55% 1-Year Est. Return
AC
AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return
NA
NWM Advisors San Luis Obispo, California $110M AUM
NMC
New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return
BCM
Bond Capital Management San Francisco, California $110M AUM 16.91% 1-Year Est. Return

Forefront Analytics's Q3 2021 Portfolio in Review

As of Q3 2021, Forefront Analytics held 76 positions worth $274M, up 8.8% from $252M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Forefront Analytics deployed $26.5M of net new capital in Q3 2021, opening 9 new positions and adding to 45 existing holdings. Its largest new stake was State Street SPDR MSCI USA Gender Diversity ETF: 45,964 shares worth $4.64M.

By sector, the portfolio is most concentrated in Financials at 0.82% of assets, down from 0.87% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alamos Gold, an estimated $110K trimmed.

  • Forefront Analytics's largest Q3 2021 buy was State Street SPDR MSCI USA Gender Diversity ETF: 45,964 shares worth $4.64M.
  • Forefront Analytics added most to Invesco S&P Global Water Index ETF in Q3 2021, an estimated $20.3M increase.
  • Forefront Analytics's biggest Q3 2021 reduction was Alamos Gold, cutting an estimated $110K.
  • Forefront Analytics fully exited Invesco Solar ETF in Q3 2021, selling an estimated $3.87M.
  • Forefront Analytics's ten largest holdings make up 53% of its $274M portfolio in Q3 2021.
  • Forefront Analytics opened 9 new positions and closed 8 in Q3 2021.
  • Forefront Analytics's portfolio value rose 8.8% quarter-over-quarter to $274M.

Based on Forefront Analytics's 13F filing for Q3 2021, filed 15 Nov 2021.